The company is investing in expanding its production capacity because of an increase in turnover, Egis CEO István Hodász was cited as saying by state news agency MTI.
The company will build a packaging plant and upgrade the facility to allow the production of new oncological products and medicines.
Egis expects to increase its export sales, Hodász added. Egis exports around 75% of its products, and has sales in more than 50 countries.